Pfizer seeks to put a stop to the COVID-19 Omicron variant, for which it announced that they are already working on a vaccine that neutralizes it.
According to Albert Bourla, executive director of the pharmaceutical company, although they are confident that the new pill, as well as the vaccine against COVID-19, will be effective for this new variant, manufacturing of a new vaccine has already begun.
The executive director assured that Pfizer made specific vaccines for the Delta and Beta variants, but they were not used because the original vaccine also combated them.
This new variant B.1.1.529 was identified in South Africa for the first time and according to the World Health Organization (WHO) it is a "very high" global risk.
Through a document, the WHO declared that taking into account the high mutations of Ómicron, with the potential to be more resistant to immunization and more contagious, the risk of the variant being transmitted throughout the world is “high”.
Related NotesMore from the author
This year 50 indigenous communities of Michoacán will seek their direct budget
They mark roads to improve the safety of pedestrians and motorists
SEFECO presents work plan for 2022 to councilors
Leave a comment Cancel reply
This site uses Akismet to reduce spam. Learn how your comment data is processed.